A recent study on the effect of aspirin came up with a surprising result that
Aspirin has "triple whammy" cancer-busting properties.
It not only protects from cancer but can also trigger a "double hit" on existing
cancer cells.
The findings of the study suggest that, taking a low dose of Aspirin pill could be helpful to combat cancer, which is already prescribed to protect against heart disease at present.
Scientists at the University of Bristol found that aspirin can prohibit the cells from mutating and becoming cancerous by starving them of essential nutrition.
"This means a daily low dose could prevent cancer but more research is needed," the Daily Express quoted Dr Yi Feng, lead author of the study in Current Biology, as saying.
A second Cancer Research-funded study, published in Gastroenterology, reveals that how a recommended aspirin dose can kill cancer cells by regulating two processes that influence the use of energy in cells.
Scientists at Edinburgh and Dundee universities say this "double hit" causes cancer cells to destroy themselves.
Dr Farhat Din, at the University of Edinburgh, said of the two studies: "Aspirin is targeting on multiple levels. It can stop cancer tumours from forming in the first instance and attack them directly when they have formed."
Currently, a lot of people already take a daily dose of aspirin against heart disease and strokes, although long-term use can also lead to some high-risk groups.
-With inputs from ANI
|
|
Comments:
